WallStreetZenWallStreetZen

NASDAQ: ENSC
Ensysce Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ENSC earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$10.6M
Current Profit Margin
0%

ENSC Return on Equity

Current Company
-780.2%
Current Industry
-63.5%
Current Market
188%
ENSC's Return on Equity (-780.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ENSC announces earnings.

ENSC Return on Assets

Current Company
-262.4%
Current Industry
2.9%
ENSC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ENSC Return on Capital Employed

Current Company
1,641.78%
Current Industry
19.5%
ENSC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ENSC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ENSC$0.00-$10.26M-$10.63MN/AN/A
GNPX$0.00-$30.85M-$30.86MN/AN/A
PALI$250.00k-$12.20M-$12.32M-0.78%N/A
KTRA$0.00-$10.58M-$10.77MN/AN/A
SCPX$2.23M-$48.05M-$51.96M-12.53%N/A
View Top Biotech Stocks

ENSC earnings dates

Next earnings date
May 13, 2024

Ensysce Biosciences Earnings & Revenue FAQ

What were ENSC's earnings last quarter?

On Invalid Date, Ensysce Biosciences (NASDAQ: ENSC) reported Q4 2023 earnings per share (EPS) of -$1.37, up 192.57% year over year. Total Ensysce Biosciences earnings for the quarter were -$3.50 million. In the same quarter last year, Ensysce Biosciences's earnings per share (EPS) was $1.48.

If you're new to stock investing, here's how to buy Ensysce Biosciences stock.

What was ENSC's earnings growth in the past year?

As of Q2 2024, Ensysce Biosciences's earnings has grown year over year. Ensysce Biosciences's earnings in the past year totalled -$10.63 million.

What is ENSC's earnings date?

Ensysce Biosciences's earnings date is Invalid Date. Add ENSC to your watchlist to be reminded of ENSC's next earnings announcement.

What was ENSC's revenue last quarter?

On Invalid Date, Ensysce Biosciences (NASDAQ: ENSC) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Ensysce Biosciences's revenue was $0.00.

What was ENSC's revenue growth in the past year?

As of Q2 2024, Ensysce Biosciences's revenue has grown null year over year. Ensysce Biosciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.